About
Transfusion Technologies
Areas of Focus
Categories
Surgical DeviceBoston & New England
Team (27)
Andrew Dunham
CEO & CTO, Hemanext since 2015 25 + years in medical devices & pharma
Hemanext
executive
Angelo D'Alessandro
Professor of Biochemistry and Molecular Genetics, Director of the Metabolomics Core, Director of Mass Spectrometry – Colorado Cancer Center, University of Colorado Anschutz Medical Campus
Hemanext
team_member
Biree Andemariam
MD, Director, New England Sickle Cell Institute & Connecticut Bleeding Disorders Center, Associate Professor of Medicine at University of Connecticut, Chief Medical Officer of the Sickle Cell Disease...
Hemanext
executive
Daan Kok
EVP and GM EMEA, Hemanext since 2022 15+ years Commercialization in Pharma
Hemanext
team_member
Eduardo Avayú
Hemanext
team_member
Eric Newman
Chief Financial Officer, Hemanext since 2018 20+ years Finance in medical devices
Hemanext
executive
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
10
As Collaborator
1
Total Enrollment
1,221
By Phase
NA: 2PHASE2: 2
By Status
COMPLETED: 7NOT_YET_RECRUITING: 1ENROLLING_BY_INVITATION: 1RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06743113Lead Sponsor
Hypoxic Red Blood Cells in Sickle Cell Anemia
NANot yet recruiting
48 participants
Started: Jan 31, 2026 · Completed: Jun 30, 2028
NCT07055503Collaborator
Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients
N/AEnrolling by invitation
30 participants
Started: Apr 23, 2025 · Completed: May 31, 2027
NCT06685848Lead Sponsor
Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion
NARecruiting
24 participants
Started: Nov 29, 2024 · Completed: Dec 15, 2026
NCT06064643Lead Sponsor
The Lived Experience of People With Von Willebrand Disease
N/ACompleted
611 participants
Started: Dec 8, 2023 · Completed: Jun 30, 2025
NCT05314751Lead Sponsor
Learning to Live With Non-severe Haemophilia
N/ACompleted
165 participants
Started: Dec 21, 2022 · Completed: Sep 29, 2023
Locations (1)
Headquarters
Avon, MA, United States
Map
Loading map...